COMMUNIQUÉS West-GlobeNewswire

Transactions in relation to share buyback program
27/08/2019
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 1, 2019, in accordance with article 5 of Regulation (EU) no. 596/2014 of April 16, 2014 on [...]
ViroGates and QIAGEN announces a partnership to launch suPARnostic® Quick Triage on QIAGEN’s automated Lateral Flow (aLF) platform
27/08/2019
Company announcement 11-2019 Birkerød, Denmark and Hilden, Germany, 27 August 2019 ViroGates A/S (Nasdaq First North Denmark: VIRO), who delivers blood test systems, primarily for emergency departments in hospitals, [...]
Spark Therapeutics Announces Change of Location for Annual Meeting of Stockholders
27/08/2019
PHILADELPHIA, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), a fully-integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, announced today the [...]
VIVUS to Share Qsymia® Safety and Efficacy Data with a Global Audience at ICOMES & AOCO 2019
27/08/2019
-Conference in Seoul provides opportunity to introduce an international audience to the clinical safety and benefits of Qsymia following its approval in the Republic of Korea- CAMPBELL, Calif., Aug. 27, 2019 (GLOBE [...]
Harrow Health to Attend Lake Street’s 3rd Annual Best Ideas Growth Conference September 12, 2019
27/08/2019
NASHVILLE, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that it will be attending Lake Street’s 3rd Annual BIG Conference September 12, 2019. Mark L. Baum, CEO, and Andrew Boll, [...]
Orchestra BioMed™ Appoints Dennis Donohoe, M.D., Leading Clinical Development Expert, as Chief Medical Officer
27/08/2019
Dr. Donohoe brings nearly 30 years of successful clinical and regulatory experience advancing medical devices in the cardiology and endovascular space NEW HOPE, Pa., Aug. 27, 2019 (GLOBE NEWSWIRE) -- Orchestra BioMed, [...]
ProMIS Neurosciences Appoints Internationally Recognized Researcher in Alzheimer’s Disease in Down Syndrome Dr. Andre Strydom to its Scientific Advisory Board
27/08/2019
TORONTO and CAMBRIDGE, Mass., Aug. 27, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting [...]
Cytokinetics and Cure SMA Renew Partnership to Advance Education and Awareness of SMA
27/08/2019
ELK GROVE VILLAGE, Ill. and SOUTH SAN FRANCISCO, Calif., Aug. 27, 2019 (GLOBE NEWSWIRE) -- Cure SMA and Cytokinetics (Nasdaq:CYTK) today announced the renewal of their partnership to increase education, awareness, [...]
Amunix Pharmaceuticals Announces the Appointment of Dr. Maninder Hora as Chief Technical Operations Officer
27/08/2019
MOUNTAIN VIEW, Calif., Aug. 27, 2019 (GLOBE NEWSWIRE) -- Amunix Pharmaceuticals, Inc. (“Amunix”), a biopharmaceutical company focused on enabling the promise of potent immune-activating biotherapeutics in solid tumors, [...]
Arvinas Announces the Initiation of Patient Dosing in a First-in-Human Phase 1 Study of ARV-471, an Estrogen Receptor-Targeting PROTAC® Protein Degrader
27/08/2019
Trial is evaluating the safety and tolerability of ARV-471 in patients with locally advanced or metastatic ER positive / HER2 negative breast cancer NEW HAVEN, Conn., Aug. 27, 2019 (GLOBE NEWSWIRE) -- Arvinas, Inc. ( [...]
Axogen to Participate in the 74th Annual American Society for Surgery of the Hand Meeting
27/08/2019
Updated outcomes data from the RANGER ® Registry’s MATCH SM cohort will be presented during scientific sessions ALACHUA, Fla., Aug. 27, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing [...]
Orchard Therapeutics Announces Presentation of Data from Neurometabolic Portfolio at Upcoming Society for the Study of Inborn Errors of Metabolism (SSIEM) 2019 Annual Symposium
27/08/2019
Mucopolysaccharidosis Type I and Metachromatic Leukodystrophy Abstracts Accepted for Oral Presentations BOSTON and LONDON, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a leading commercial- [...]
RedHill Biopharma to Present at Upcoming Investor Conferences in September
27/08/2019
TEL-AVIV, Israel and RALEIGH, N.C., Aug. 27, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL ) (Tel-Aviv Stock Exchange: RDHL ) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
BriaCell Announces Participation at the 21st Annual Global Investment Conference in New York City September 8-10, 2019
27/08/2019
BERKELEY, Calif. and VANCOUVER, British Columbia, Aug. 27, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company [...]
Amarin Provides Overview on Growing Global Attention on REDUCE-IT™ Results and Cardiovascular Risk Management Beyond Cholesterol Management
27/08/2019
Multiple Papers and Presentations Highlight REDUCE-IT and Vascepa ® Potential Mechanisms of Action of Vascepa Becoming Better Understood American Heart Association References REDUCE-IT in Scientific Advisory BEDMINSTER [...]
FDA Provides Guidance on Clinical Pathway to Marketing Application for Revascor in End-Stage Heart Failure Patients With an LVAD
27/08/2019
Primary Endpoint of Confirmatory Trial to be Reduction in Major Mucosal Bleeding Events NEW YORK and MELBOURNE, Australia, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in [...]
New Data From Aslan’s Study of Varlitinib in China Accepted as Late-Breaking Oral Presentation at 2019 CSCO Annual Meeting
27/08/2019
SINGAPORE, Aug. 27, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology and immunology focused biopharma company, today announced that a late-breaking abstract detailing [...]
The Alliance for Regenerative Medicine Releases Statement of Principles on Genome Editing
27/08/2019
WASHINGTON, D.C., Aug. 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader [...]
Zealand Pharma relocates headquarters to accommodate growth
27/08/2019
Press Release – No. 18 / 2019 Copenhagen, August 27, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of [...]

Pages